Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-10T01:56:12.823Z Has data issue: false hasContentIssue false

Bismuth iodoform paraffin paste: a review

Published online by Cambridge University Press:  14 September 2012

K MacDonald
Affiliation:
Glan Clwyd Hospital, Rhyl, UK
A Farboud
Affiliation:
Glan Clwyd Hospital, Rhyl, UK
A Jardine
Affiliation:
Royal United Hospital, Bath, UK
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editors
Copyright
Copyright © JLO (1984) Limited 2012

Dear Sirs,

We read with great interest the above paper by Crossland and Bath.Reference Crossland and Bath 1 The article discusses possible alternatives to bismuth iodoform paraffin paste (BIPP), which our group feels is quite a pertinent issue given the recent BIPP supply problems in the UK.

We would like to briefly add to the list of alternative agents suitable for use in otology, and also to give recommendations based on our practice.

There have been very few studies suggesting alternatives to BIPP. Chevretton et al. concluded that Xeroform® is inferior to BIPP due to an increase in adverse effects.Reference Chevretton, McRae and Booth 2 Nakhla et al. compared BIPP and Tri-adcortyl® ointment ear dressing, and found no difference in outcome between the two preparations.Reference Nakhla, Takwoingi and Sinha 3 Zeitoun et al. reviewed the use of BIPP, Pope wicks, Silastic® sheeting and Tri-adcortyl, and found that all had similar success rates when used following middle-ear surgery.Reference Zeitoun, Sandhu, Kuo and Macnamara 4 Unfortunately, Tri-adcortyl was withdrawn in 2009 due to reduced demand, and a suitable substitute is not readily available.

Our group suggests the use of Polyfax® as an alternative to BIPP. Polyfax is a topical antibacterial agent composed of polymyxin B sulphate and bacitracin zinc. It is currently unlicensed for use in the ear but is used for the treatment of infected wounds, burns and skin grafts. 5 When used topically, it has a small side effect profile and is neither ototoxic nor vestibulotoxic. 5

Polymyxin B, the antibiotic present in Polyfax, is also present within Otosporin® eardrops. In this latter preparation it is combined with neomycin and hydrocortisone, and provides effective therapy for otitis externa. This highlights the safety and efficacy of polymyxin B when used within the ear.

No evidence exists for the efficacy of Polyfax following middle-ear surgery. We have incorporated Polyfax into our routine practice and have achieved outcomes comparable to those for BIPP usage.

Our group advocates the use of Polyfax following middle-ear surgery. We apply it without gauze and remove it by microsuction two to three weeks later. Routine ear protection advice is given to the patient.

We are in the process of conducting a retrospective review of our caseload; however, more research is needed into the use of Polyfax following ear surgery, and its potential as an alternative to BIPP.

References

1 Crossland, CJ, Bath, AP. Bismuth iodoform paraffin paste: a review. J Laryngol Otol 2011;125:891–5CrossRefGoogle ScholarPubMed
2 Chevretton, EB, McRae, RD, Booth, JB. Mastoidectomy packs: Xeroform or BIPP? J Laryngol Otol 1991;105:916–17CrossRefGoogle ScholarPubMed
3 Nakhla, V, Takwoingi, YM, Sinha, A. Myringoplasty: a comparison of bismuth iodoform paraffin paste gauze pack and tri-adcortyl ointment ear dressing. J Laryngol Otol 2007;121:329–32CrossRefGoogle ScholarPubMed
4 Zeitoun, H, Sandhu, GS, Kuo, M, Macnamara, M. A randomised prospective trial to compare four different ear packs following permeatal middle ear surgery. J Laryngol Otol 1998:112;140–4CrossRefGoogle ScholarPubMed
5 EPG: Polyfax Ointment. In: http://www.epgonline.org/drugs/polyfax/ [20 July 2012]Google Scholar